Pharma
Global Renal Disease Market Opportunities and Forecast 2022-2029
  • DLR2184
  • 03 November, 2022
  • Pharma & Healthcare
  • Pages: 120
  • Global
Global Renal Disease Market Opportunities and Forecast 2022-2029

Market Overview

The global renal disease market is expected to grow at a CAGR of 8.2%% during the forecast period (2022-2029). The rising prevalence of chronic kidney diseases and the growing number of patients with end-stage renal disease are the major factors driving the growth of this market.


In addition, the increasing awareness about the early detection and treatment of renal diseases, the availability of advanced treatments, and the growing number of clinical trials are also contributing to the growth of this market. However, the high cost of treatment and lack of awareness in developing countries are restraining the growth of this market.

The global renal disease market is segmented by type, cause, diagnosis, and treatment. By type, the market is classified into acute kidney injury (AKI), chronic kidney disease (CKD), end-stage renal disease (ESRD), and polycystic kidney disease (PKD). By cause, the market is categorized into diabetes mellitus, hypertension, glomerulonephritis, urinary tract infection, nephrotic syndrome, and others.

By diagnosis, the market is divided into blood tests, urine tests, imaging tests, biopsies, and others. By treatment, the market is classified into dialysis (hemodialysis and peritoneal dialysis), transplantation (kidney transplantation and living donor transplantation), medications (diuretics, ACE inhibitors/ARBs/calcium channel blockers/antihypertensives

Renal disease is a debilitating and often fatal condition that affects millions of people worldwide. According to the World Health Organization, renal disease is the ninth leading cause of death globally, and its incidence is rising. There is no cure for renal disease, but early diagnosis and treatment can improve patient outcomes and slow the progression of the disease. With the aging population and the rise in chronic diseases such as diabetes and hypertension, the global renal disease market is expected to grow significantly over the next decade.

Renal diseases are disorders of the kidney caused by genetic problems, diabetes, and high blood pressure. The most common type of renal disease is chronic kidney disease (CKD), which progresses slowly over time and may lead to complete kidney failure.

The market has been segmented on the basis of disease type, treatment type, and geography. By disease type, CKD holds the largest share of the market due to its increasing prevalence across the globe. By treatment type, dialysis is the most widely used treatment for renal diseases, followed by transplantation. Geographically, North America dominates the global renal disease market due to the rising incidence of kidney diseases and the availability of advanced treatments in this region.

The major players operating in the global renal disease market are Fresenius Medical Care AG & Co., DaVita Healthcare Partners Inc., Baxter International Inc., B Braun Melsungen AG, and Diaverum Deutschland GmbH.

Market Drivers and Trends

There is a growing awareness of renal diseases and their impact on patient health and quality of life. This has led to a greater demand for treatments that can improve outcomes and reduce the burden of disease. The prevalence of renal diseases is also increasing due to the aging population and the rise in risk factors such as obesity, diabetes, and hypertension. The main drivers of market growth include the increasing prevalence of renal diseases, the launch of new therapies, and the growing awareness of kidney transplantation.

The main trends in the market include the rising use of telemedicine, the increasing use of artificial intelligence (AI) in diagnosis and treatment, and the growing number of home dialysis programs.

Report Includes


An overview of the global Renal Disease market, and related technologies and developments. Analyses of global market trends, with historical data from 2018, 2019, and 2020 estimates and projections of CAGRs through 2029. It also includes breakdowns of the overall Renal Disease market along with various segments, and by geographic region. Analysis of the stakeholder value chain in the Renal Disease market and comprehensive profiles of leading companies in the industry

Report Scope

The report forecasts the size of the Renal Disease market for components from 2022 through 2029
The Executive Summary provides a snapshot of the key findings of the report. The introduction chapter includes the research scope, market segmentation, research methodology, and definitions and assumptions. It involves extremely rigorous scientific methods, tools, and techniques to estimate the market size. Exhaustive secondary research is being carried out to collect information related to the market, the parent market, and the peer market. Primary research is undertaken to validate the assumptions, findings, and sizing with industry experts and professionals across the value chain of the market. Both top-down and bottom-up approaches are employed to estimate the complete market size.

The chapter on market dynamics includes market drivers, restraints, and opportunities which helps familiarise with market potential and upcoming opportunities. The chapter on key insights includes emerging trends from major countries, the latest technological advancement, regulatory landscape, SWOT analysis, and Porter's five forces analysis. This chapter provides detailed insights into the market, which derives the market trends, changing phase of investments, and scope of profit potential, and helps to take appropriate business decisions. The chapter on competitive analysis includes the profiling of leading companies in the global market to map the leading companies and their focus of interest in the market.

After deriving the market size from the market size estimation process, the total market has been split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics for all segments and sub-segments, data triangulation and market breakdown procedures are being used. The data triangulation is carried out by studying various factors and trends from demand and supply perspectives.

Segmentation Analysis:

The global renal disease market is classified on the basis of product type, disease type, and geography.

Global Renal Disease Market Competitive Analysis:
Key players in the Global Renal Disease market are Abbott (US), Amgen Inc. (US), AstraZeneca (US), Bristol-Myers Squibb Company (US), F. Hoffmann-La Roche Ltd (Switzerland), Fresenius Medical Care AG & Co. KGaA (UK), GlaxoSmithKline PLC (UK), Keryx Biopharmaceuticals, Inc (US), Kissei Pharmaceutical Co., Ltd (Japan), Novartis AG (Switzerland), Pfizer Inc. (US), Sanofi SA (France), and Teva Pharmaceutical Industries Ltd (Israel) among other players.

*All our reports are customizable as per customer requirements
This study forecasts revenue and volume growth at global, regional, and country levels from 2018 to 2029. The global Renal Disease market is distributed on the basis of the below-mentioned segments:

Global Renal Disease market, By Type:
  • Acute Kidney Problems
  • Chronic Kidney Diseases
  • Others
Global Renal Disease market, By Application:
  • Hospital
  • Clinic
  • Research Center
  • Others
Global Renal Disease market, By Region:
  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa


Renal Disease MARKET STUDY GLOBAL MARKET ANALYSIS, INSIGHTS AND FORECAST, 2020-2027

    1. Introduction

    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions

    2. Executive Summary

      3. Market Dynamics

      • 3.1. Market Drivers
      • 3.2. Market Restraints
      • 3.3. Market Opportunities

      4. Key Insights

      • 4.1. Key Emerging Trends – For Major Countries
      • 4.2. Latest Technological Advancement
      • 4.3. Regulatory Landscape
      • 4.4. Industry SWOT Analysis
      • 4.5. Porters Five Forces Analysis

      5. Global Renal Disease Market Analysis (USD Billion), Insights and Forecast, 2016-2027

      • 5.1. Key Findings / Summary
      • 5.2. Market Analysis, Insights and Forecast – By Segment 1
        • 5.2.1. Sub-Segment 1
        • 5.2.2. Sub-Segment 2
      • 5.3. Market Analysis, Insights and Forecast – By Segment 2
        • 5.3.1. Sub-Segment 1
        • 5.3.2. Sub-Segment 2
        • 5.3.3. Sub-Segment 3
        • 5.3.4. Others
      • 5.4. Market Analysis, Insights and Forecast – By Segment 3
        • 5.4.1. Sub-Segment 1
        • 5.4.2. Sub-Segment 2
        • 5.4.3. Sub-Segment 3
        • 5.4.4. Others
      • 5.5. Market Analysis, Insights and Forecast – By Region
        • 5.5.1. North America
        • 5.5.2. Latin America
        • 5.5.3. Europe
        • 5.5.4. Asia Pacific
        • 5.5.5. Middle East and Africa

      6. North America Renal Disease Market Analysis (USD Billion), Insights and Forecast, 2016-2027

      • 6.1. Key Findings / Summary
      • 6.2. Market Analysis, Insights and Forecast – By Segment 1
        • 6.2.1. Sub-Segment 1
        • 6.2.2. Sub-Segment 2
      • 6.3. Market Analysis, Insights and Forecast – By Segment 2
        • 6.3.1. Sub-Segment 1
        • 6.3.2. Sub-Segment 2
        • 6.3.3. Sub-Segment 3
        • 6.3.4. Others
      • 6.4. Market Analysis, Insights and Forecast – By Segment 3
        • 6.4.1. Sub-Segment 1
        • 6.4.2. Sub-Segment 2
        • 6.4.3. Sub-Segment 3
        • 6.4.4. Others
      • 6.5. Market Analysis, Insights and Forecast – By Country
        • 6.5.1. U.S.
        • 6.5.2. Canada

      7. Latin America Renal Disease Market Analysis (USD Billion), Insights and Forecast, 2016-2027

      • 7.1. Key Findings / Summary
      • 7.2. Market Analysis, Insights and Forecast – By Segment 1
        • 7.2.1. Sub-Segment 1
        • 7.2.2. Sub-Segment 2
      • 7.3. Market Analysis, Insights and Forecast – By Segment 2
        • 7.3.1. Sub-Segment 1
        • 7.3.2. Sub-Segment 2
        • 7.3.3. Sub-Segment 3
        • 7.3.4. Others
      • 7.4. Market Analysis, Insights and Forecast – By Segment 3
        • 7.4.1. Sub-Segment 1
        • 7.4.2. Sub-Segment 2
        • 7.4.3. Sub-Segment 3
        • 7.4.4. Others
      • 7.5. Insights and Forecast – By Country
        • 7.5.1. Brazil
        • 7.5.2. Mexico
        • 7.5.3. Rest of Latin America

      8. Europe Renal Disease Market Analysis (USD Billion), Insights and Forecast, 2016-2027

      • 8.1. Key Findings / Summary
      • 8.2. Market Analysis, Insights and Forecast – By Segment 1
        • 8.2.1. Sub-Segment 1
        • 8.2.2. Sub-Segment 2
      • 8.3. Market Analysis, Insights and Forecast – By Segment 2
        • 8.3.1. Sub-Segment 1
        • 8.3.2. Sub-Segment 2
        • 8.3.3. Sub-Segment 3
        • 8.3.4. Others
      • 8.4. Market Analysis, Insights and Forecast – By Segment 3
        • 8.4.1. Sub-Segment 1
        • 8.4.2. Sub-Segment 2
        • 8.4.3. Sub-Segment 3
        • 8.4.4. Others
      • 8.5. Market Analysis, Insights and Forecast – By Country
        • 8.5.1. UK
        • 8.5.2. Germany
        • 8.5.3. France
        • 8.5.4. Italy
        • 8.5.5. Spain
        • 8.5.6. Russia
        • 8.5.7. Rest of Europe

      9. Asia Pacific Renal Disease Market Analysis (USD Billion), Insights and Forecast, 2016-2027

      • 9.1. Key Findings / Summary
      • 9.2. Market Analysis, Insights and Forecast – By Segment 1
        • 9.2.1. Sub-Segment 1
        • 9.2.2. Sub-Segment 2
      • 9.3. Market Analysis, Insights and Forecast – By Segment 2
        • 9.3.1. Sub-Segment 1
        • 9.3.2. Sub-Segment 2
        • 9.3.3. Sub-Segment 3
        • 9.3.4. Others
      • 9.4. Market Analysis, Insights and Forecast – By Segment 3
        • 9.4.1. Sub-Segment 1
        • 9.4.2. Sub-Segment 2
        • 9.4.3. Sub-Segment 3
        • 9.4.4. Others
      • 9.5. Market Analysis, Insights and Forecast – By Country
        • 9.5.1. China
        • 9.5.2. India
        • 9.5.3. Japan
        • 9.5.4. Australia
        • 9.5.5. South East Asia
        • 9.5.6. Rest of Asia Pacific

      10. Middle East & Africa Renal Disease Market Analysis (USD Billion), Insights and Forecast, 2016-2027

      • 10.1. Key Findings / Summary
      • 10.2. Market Analysis, Insights and Forecast – By Segment 1
        • 10.2.1. Sub-Segment 1
        • 10.2.2. Sub-Segment 2
      • 10.3. Market Analysis, Insights and Forecast – By Segment 2
        • 10.3.1. Sub-Segment 1
        • 10.3.2. Sub-Segment 2
        • 10.3.3. Sub-Segment 3
        • 10.3.4. Others
      • 10.4. Market Analysis, Insights and Forecast – By Segment 3
        • 10.4.1. Sub-Segment 1
        • 10.4.2. Sub-Segment 2
        • 10.4.3. Sub-Segment 3
        • 10.4.4. Others
      • 10.5. Market Analysis, Insights and Forecast – By Country
        • 10.5.1. GCC
        • 10.5.2. South Africa
        • 10.5.3. Rest of Middle East & Africa

      11. Competitive Analysis

      • 11.1. Company Market Share Analysis, 2018
      • 11.2. Key Industry Developments
      • 11.3. Company Profile
        • 11.3.1. Company 1
          • 11.3.1.1. Business Overview
          • 11.3.1.2. Segment 1 & Service Offering
          • 11.3.1.3. Overall Revenue
          • 11.3.1.4. Geographic Presence
          • 11.3.1.5. Recent Development
        *Similar details will be provided for the following companies
        • 11.3.2. Company 2
        • 11.3.3. Company 3
        • 11.3.4. Company 4
        • 11.3.5. Company 5
        • 11.3.6. Company 6
        • 11.3.7. Company 7
        • 11.3.8. Company 8
        • 11.3.9. Company 9
        • 11.3.10. Company 10
        • 11.3.11. Company 11
        • 11.3.12. Company 12
      List of Figures

      Figure 1: Global Renal Disease Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
      Figure 2: Global Renal Disease Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 3: Global Renal Disease Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 4: Global Renal Disease Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 5: Global Renal Disease Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 6: Global Renal Disease Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 7: Global Renal Disease Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 8: Global Renal Disease Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 9: Global Renal Disease Market Forecast (USD Billion), by Others, 2016-2027
      Figure 10: Global Renal Disease Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 11: Global Renal Disease Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 12: Global Renal Disease Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 13: Global Renal Disease Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 14: Global Renal Disease Market Forecast (USD Billion), by Others, 2016-2027
      Figure 15: Global Renal Disease Market Value (USD Billion), by Region, 2019 & 2027
      Figure 16: North America Renal Disease Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 17: North America Renal Disease Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 18: North America Renal Disease Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 19: North America Renal Disease Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 20: North America Renal Disease Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 21: North America Renal Disease Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 22: North America Renal Disease Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 23: North America Renal Disease Market Forecast (USD Billion), by Others, 2016-2027
      Figure 24: North America Renal Disease Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 25: North America Renal Disease Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 26: North America Renal Disease Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 27: North America Renal Disease Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 28: North America Renal Disease Market Forecast (USD Billion), by Others, 2016-2027
      Figure 29: North America Renal Disease Market Forecast (USD Billion), by U.S., 2016-2027
      Figure 30: North America Renal Disease Market Forecast (USD Billion), by Canada, 2016-2027
      Figure 31: Latin America Renal Disease Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 32: Latin America Renal Disease Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 33: Latin America Renal Disease Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 34: Latin America Renal Disease Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 35: Latin America Renal Disease Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 36: Latin America Renal Disease Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 37: Latin America Renal Disease Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 38: Latin America Renal Disease Market Forecast (USD Billion), by Others, 2016-2027
      Figure 39: Latin America Renal Disease Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 40: Latin America Renal Disease Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 41: Latin America Renal Disease Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 42: Latin America Renal Disease Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 43: Latin America Renal Disease Market Forecast (USD Billion), by Others, 2016-2027
      Figure 44: Latin America Renal Disease Market Forecast (USD Billion), by Brazil, 2016-2027
      Figure 45: Latin America Renal Disease Market Forecast (USD Billion), by Mexico, 2016-2027
      Figure 46: Latin America Renal Disease Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
      Figure 47: Europe Renal Disease Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 48: Europe Renal Disease Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 49: Europe Renal Disease Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 50: Europe Renal Disease Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 51: Europe Renal Disease Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 52: Europe Renal Disease Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 53: Europe Renal Disease Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 54: Europe Renal Disease Market Forecast (USD Billion), by Others, 2016-2027
      Figure 55: Europe Renal Disease Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 56: Europe Renal Disease Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 57: Europe Renal Disease Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 58: Europe Renal Disease Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 59: Europe Renal Disease Market Forecast (USD Billion), by Others, 2016-2027
      Figure 60: Europe Renal Disease Market Forecast (USD Billion), by U.K., 2016-2027
      Figure 61: Europe Renal Disease Market Forecast (USD Billion), by Germany, 2016-2027
      Figure 62: Europe Renal Disease Market Forecast (USD Billion), by France, 2016-2027
      Figure 63: Europe Renal Disease Market Forecast (USD Billion), by Italy, 2016-2027
      Figure 64: Europe Renal Disease Market Forecast (USD Billion), by Spain, 2016-2027
      Figure 65: Europe Renal Disease Market Forecast (USD Billion), by Russia, 2016-2027
      Figure 66: Europe Renal Disease Market Forecast (USD Billion), by Rest of Europe, 2016-2027
      Figure 67: Asia Pacific Renal Disease Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 68: Asia Pacific Renal Disease Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 69: Asia Pacific Renal Disease Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 70: Asia Pacific Renal Disease Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 71: Asia Pacific Renal Disease Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 72: Asia Pacific Renal Disease Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 73: Asia Pacific Renal Disease Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 74: Asia Pacific Renal Disease Market Forecast (USD Billion), by Others, 2016-2027
      Figure 75: Asia Pacific Renal Disease Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 76: Asia Pacific Renal Disease Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 77: Asia Pacific Renal Disease Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 78: Asia Pacific Renal Disease Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 79: Asia Pacific Renal Disease Market Forecast (USD Billion), by Others, 2016-2027
      Figure 80: Asia Pacific Renal Disease Market Forecast (USD Billion), by China, 2016-2027
      Figure 81: Asia Pacific Renal Disease Market Forecast (USD Billion), by India, 2016-2027
      Figure 82: Asia Pacific Renal Disease Market Forecast (USD Billion), by Japan, 2016-2027
      Figure 83: Asia Pacific Renal Disease Market Forecast (USD Billion), by Australia, 2016-2027
      Figure 84: Asia Pacific Renal Disease Market Forecast (USD Billion), by Southeast Asia, 2016-2027
      Figure 85: Asia Pacific Renal Disease Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
      Figure 86: Middle East & Africa Renal Disease Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 87: Middle East & Africa Renal Disease Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 88: Middle East & Africa Renal Disease Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 89: Middle East & Africa Renal Disease Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 90: Middle East & Africa Renal Disease Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 91: Middle East & Africa Renal Disease Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 92: Middle East & Africa Renal Disease Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 93: Middle East & Africa Renal Disease Market Forecast (USD Billion), by Others, 2016-2027
      Figure 94: Middle East & Africa Renal Disease Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 95: Middle East & Africa Renal Disease Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 96: Middle East & Africa Renal Disease Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 97: Middle East & Africa Renal Disease Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 98: Middle East & Africa Renal Disease Market Forecast (USD Billion), by Others, 2016-2027
      Figure 99: Middle East & Africa Renal Disease Market Forecast (USD Billion), by GCC, 2016-2027
      Figure 100: Middle East & Africa Renal Disease Market Forecast (USD Billion), by South Africa, 2016-2027
      Figure 101: Middle East & Africa Renal Disease Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027 
      List of Tables
      Table 1: Global Renal Disease Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 2: Global Renal Disease Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 3: Global Renal Disease Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 4: Global Renal Disease Market Revenue (USD Billion) Forecast, by Region, 2016-2027
      Table 5: North America Renal Disease Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 6: North America Renal Disease Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 7: North America Renal Disease Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 8: North America Renal Disease Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 9: Europe Renal Disease Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 10: Europe Renal Disease Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 11: Europe Renal Disease Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 12: Europe Renal Disease Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 13: Latin America Renal Disease Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 14: Latin America Renal Disease Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 15: Latin America Renal Disease Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 16: Latin America Renal Disease Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 17: Asia Pacific Renal Disease Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 18: Asia Pacific Renal Disease Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 19: Asia Pacific Renal Disease Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 20: Asia Pacific Renal Disease Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 21: Middle East & Africa Renal Disease Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 22: Middle East & Africa Renal Disease Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 23: Middle East & Africa Renal Disease Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 24: Middle East & Africa Renal Disease Market Revenue (USD Billion) Forecast, by Country, 2016-2027

      Report You Might be Interested

      Choose License Type

      • USD
      • GBP
      • EURO
      • INR
      Credit card Logo

      Happy To Assist You

      Have a Question? email us at

      [email protected]

      Or Call Us On

      US +1 360 851 1343

      IND +91 880 579 4934